A retrospective analysis of ketamine intravenous therapy for depression in real-world care settings.

McInnes, L Alison; Qian, Jimmy J; Gargeya, Rishab S; DeBattista, Charles; Heifets, Boris D

McInnes, L Alison; Qian, Jimmy J; Gargeya, Rishab S; DeBattista, Charles; Heifets, Boris D.

Afiliação

McInnes LA; Osmind, San Francisco, CA, United States. Electronic address: alison@osmind.org.
Qian JJ; Osmind, San Francisco, CA, United States; Stanford University School of Medicine, Stanford, CA, United States.
Gargeya RS; Osmind, San Francisco, CA, United States.
DeBattista C; Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, United States.
Heifets BD; Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, United States; Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, CA, United States.

J Affect Disord ; 301: 486-495, 2022 03 15.

Article em En | MEDLINE | ID: mdl-35027209

Assuntos

Transtorno Depressivo Maior; Ketamina; Depressão/tratamento farmacológico; Transtorno Depressivo Maior/tratamento farmacológico; Humanos; Infusões Intravenosas; Ketamina/uso terapêutico; Estudos Retrospectivos; Ideação Suicida

Palavras-chave

Induction; Intravenous; Ketamine; Maintenance; Major depression; Real-world

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtorno Depressivo Maior / Ketamina Tipo de estudo: Observational_studies Limite: Humans Idioma: En Revista: J Affect Disord Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google